Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis

被引:40
|
作者
Ward, MM
机构
[1] Stanford Univ, Med Ctr, Sch Med, Div Rheumatol & Immunol,Dept Med, Stanford, CA 94305 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA
关键词
lupus nephritis; systemic lupus erythematosus (SLE); cardiovascular disease; myocardial infarction; cerebrovascular disease; end-stage renal disease (ESRD);
D O I
10.1053/ajkd.2000.9792
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular and cerebrovascular diseases are common causes of morbidity and mortality in women with systemic lupus erythematosus (SLE) and are also common in patients with end-stage renal disease (ESRD), To determine whether women with ESRD caused by lupus nephritis are at greater risk for morbidity from these conditions than women with other causes of ESRD, data from the US Renal Data System were used to compare incidence rates of hospitalizations for acute myocardial infarction and cerebrovascular accident between women with ESRD caused by lupus nephritis and women with ESRD from other causes. The age- and race-adjusted incidences of hospitalizations for acute myocardial infarction during dialysis were 16.4 hospitalizations/1,000 patient-years among women with ESRD caused by lupus nephritis and 17.3 hospitalizations/1,000 patient-years among women in the comparison group (adjusted hazard ratio, 0.80; 95% confidence interval [CI], 0.58 to 1.08; P = 0.14). Adjusted incidence rates for acute myocardial infarction after renal transplantation also did not differ between these groups. Adjusted incidence rates for hospitalizations for cerebrovascular accident during dialysis were 18.5 hospitalizations/1,000 patient-years among women with ESRD caused by lupus nephritis and 19.2 hospitalizations/1,000 patient-years among women in the comparison group (adjusted hazard ratio, 0.87; 95% CI, 0.66 to 1.14; P = 0.30); incidence rates after transplantation also did not differ between groups. Risks for death from cardiovascular or cerebrovascular diseases also were not increased among women with ESRD caused by lupus nephritis, Sepsis was the most common cause of death in this group. Morbidity and mortality from acute myocardial infarction and cerebrovascular accident were substantially greater among women with ESRD caused by diabetes mellitus, Although morbidity and mortality from cardiovascular and cerebrovascular diseases are common among women with SLE, risks for these outcomes are not greater among women with ESRD caused by lupus nephritis than among other women without diabetes with ESRD, (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:516 / 525
页数:10
相关论文
共 50 条
  • [1] Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Gomez-Puerta, Jose A.
    Feldman, Candace H.
    Alarcon, Graciela S.
    Guan, Hongshu
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1453 - 1462
  • [2] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Tselios, Kostantinos
    Gladman, Dafna
    Su, Jiandong
    Urowitz, Murray
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 813 - 813
  • [3] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Deeb, Mery
    Tselios, Konstantinos
    Gladman, Dafna D.
    Su, Jiandong
    Urowitz, Murray
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Associations of Race and Ethnicity with Overall Mortality and Cardiovascular Events Among Patients with End-Stage Renal Disease Due to Lupus Nephritis
    Gomez-Puerta, Jose A.
    Waikar, Sushrut
    Alarcon, Graciela S.
    Liu, Jun
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S711 - S712
  • [5] Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease
    Picton, ML
    Foley, RN
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (05): : 497 - 500
  • [6] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [7] The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis
    Goo, YS
    Park, HC
    Choi, HY
    Kim, BS
    Park, YB
    Lee, SK
    Kang, SW
    Kim, SI
    Kim, YS
    Park, KI
    Lee, HY
    Han, DS
    Choi, KH
    YONSEI MEDICAL JOURNAL, 2004, 45 (02) : 199 - 206
  • [8] Hypocalcemia, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Hu, LQ
    ODea, R
    Murray, DC
    Barre, PE
    AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (05) : 386 - 393
  • [9] Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis
    Ward, MM
    KIDNEY INTERNATIONAL, 2000, 57 (05) : 2136 - 2143
  • [10] Access to renal transplantation among patients with end-stage renal disease due to lupus nephritis
    Ward, MM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 915 - 922